ENT Updates

Short Communication

Nicotine's Effectiveness in the Isolated Human Nasal Mucosa

Downloads

https://doi.org/10.54963/entu.v16i1.2165
Chou, Y.-L., Cheng, L.-H., Liu, S.-C., & Wang, H.-W. (2026). Nicotine’s Effectiveness in the Isolated Human Nasal Mucosa. ENT Updates, 16(1), 42–49. https://doi.org/10.54963/entu.v16i1.2165
Volume 16 Issue 1 (2026)
Copyright (c) 2026 Ying-Liang Chou, Li-Hsiang Cheng, Shao-Cheng Liu, Hsing-Won Wang
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors

  • Ying-Liang Chou

    Department of Otolaryngology–Head and Neck Surgery, Taichung Armed Forces General Hospital, Taichung 411, Taiwan
    Department of Otolaryngology–Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan
    Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung 406, Taiwan
  • Li-Hsiang Cheng

    Department of Otolaryngology–Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan
  • Shao-Cheng Liu

    Department of Otolaryngology–Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan
  • Hsing-Won Wang

    Department of Otolaryngology–Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan
    The Graduate Institute of Clinical Medicine and Department of Otolaryngology, College of Medicine, Taipei Medical University–Shuang Ho Hospital, Taipei 235, Taiwan

Received: 25 December 2025; Revised: 9 February 2026; Accepted: 27 February 2026; Published: 16 March 2026

Nicotine is a stimulant that affects the ganglia. Similar to capsaicin, it also activates sensory nerves in the airways, which leads to secretion and coughing in human subjects. The nasal mucosa can be exposed to the drug through either nasal or oral administration. The study investigated the effects of nicotine on electrically stimulated contractions of human nasal mucosa, resting tension of human nasal mucosa, and contractions induced by 10−6 M norepinephrine (NE) or 10−6 M methoxamine, a sympathetic mimetic. The purpose was to assess the direct impact of nicotine on human nasal mucosa in an in vitro laboratory setting. The findings demonstrated that the nasal mucosa contracted in a dose-dependent manner upon the addition of methoxamine to the incubation medium. Addition of nicotine at doses of 10−4 M elicited a significant relaxation response to 10–6 M methoxamine-induced mucosal strip contraction. Nicotine could inhibit electrical field stimulation-induced spike contraction and had a negligible effect on the basal tension of the nasal mucosa as the concentration increased. Adding 10−6 M nicotine to the 10−6 M NE-induced contraction, it initially induced a small reduction of the contraction, then it potentiated the contractions. This study demonstrated that high nicotine concentrations had a significant spasmolytic effect via antagonistically binding to α-adrenoceptors. Moreover, people with nasal allergies and stuffy noses who additionally utilize an α-adrenergic agonist nasal spray, oral or smoked nicotine, or both concurrently may not get relief from nasal obstruction.

Keywords:

Nicotine Sympathetic Function Human Nasal Mucosa In Vitro Study

References

  1. Arrazola, R.A.; Husten, C.G.; Cornelius, M.E.; et al. Notes from the Field: Tobacco Product Use Among Adults—United States, 2017–2023. Morb. Mortal. Wkly. Rep. 2025, 74, 118–121.
  2. Centers for Disease Control and Prevention (CDC). Tobacco Product Use among Adults—United States, 2022; Centers for Disease Control and Prevention (CDC): Atlanta, GA, USA, 2024.
  3. Meza, R.; Cao, P.; Jeon, J.; et al. Trends in US adult smoking prevalence, 2011 to 2022. JAMA Health Forum 2023, 4, e234213. DOI: https://doi.org/10.1001/jamahealthforum.2023.4213
  4. Jamal, A.; Park-Lee, E.; Birdsey, J.; et al. Tobacco product use among middle and high school students—National Youth Tobacco Survey, United States, 2024. Morb. Mortal. Wkly. Rep. 2024, 73, 917–924. DOI: https://doi.org/10.15585/mmwr.mm7341a2
  5. Romm, K.F.; Gilford Jr., C.; Das, M.; et al. Associations of rural-urban residence with daily experiences of minority stress and tobacco use among sexual minority young adults. Addict. Behav. 2026, 172, 108525. DOI: https://doi.org/10.1016/j.addbeh.2025.108525
  6. Ijaz, A.; Gehris, M.E.; Harrell, P.T.; et al. Patterns of exclusive, dual and poly tobacco products use among cancer survivors in the United States. J. Cancer Surviv. 2025. DOI: https://doi.org/10.1007/s11764-025-01918-x
  7. Pratt, K.; Hilty, A.; Jacob, P.; et al. Respiratory exposure to third hand cigarette smoke increases concentrations of urinary metabolites of nicotine. Nicotine Tob. Res. 2023, 25, 1424–1430. DOI: https://doi.org/10.1093/ntr/ntad002
  8. Almassi, A.A.; Oliver, B.G.G.; Smith, S.M. Analysis of assessment methods for detecting nicotine residue and its impact on humans: A systematic review. Int. J. Environ. Res. Public Health 2025, 22, 621. DOI: https://doi.org/10.3390/ijerph22040621
  9. Kiyohara, K.; Ikeda, T.; Ishimaru, T.; et al. Discomfort experienced due to the odor and physiological responses of residual tobacco smoke brought into workplaces by smokers on work performance and mental health. J. Epidemiol. 2025, 35, 393–401. DOI: https://doi.org/10.2188/jea.JE20240354
  10. Arastoo, S.; Haptonstall, K.P.; Choroomi, Y.; et al. Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: Role of nicotine and non-nicotine constituents. Am. J. Physiol. Heart Circ. Physiol. 2020, 319, H262–H270.
  11. Lin, V.Y.; Fain, M.D.; Jackson, P.L. Vaporized e-cigarette liquids induce ion transport dys-function in airway epithelia. Am. J. Respir. Cell Mol. Biol. 2019, 61, 162–173.
  12. Stjirne, P.; Lundblad, L.; Lundberg, J.M.; et al. Capsaicin and nicotine-sensitive afferent neurons and nasal secretion in healthy human volunteers and inpatients with vasomotor rhinitis. Br. J. Pharmacol. 1989, 96, 693–701.
  13. Greiff, L.; Wollmer, P.; Erjefält, I.; et al. Effects of nicotine on the human nasal mucosa. Thorax 1993, 48, 651–655.
  14. Carstens, E.; Carstens, M.I. Sensory Effects of Nicotine and Tobacco. Nicotine Tob. Res. 2022, 14, 306–315.
  15. Cheng, L.-H.; Lee, J.-C.; Wu, P.-C.; et al. Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis. Rhinology 2019, 57, 268–272.
  16. Wang, H.W.; Jackson, R.T. Do cholinergic neurons directly innervate nasal blood vessels? Rhinology 1988, 26, 139–146.
  17. Wang, H.-W.; Cheng, L.-H.; Lee, F.-P. Efficacy of vardenafil in human nasal mucosa. Am. J. Otolaryngol. 2020, 41, 102561. DOI: https://doi.org/10.1016/j.amjoto.2020.102561
  18. Ichimura, K.; Jackson, R.T. Evidence of alpha2-adrenoceptors in the nasal blood vessels of the dog. Arch. Otolaryngol. 1984, 110, 647–651.
  19. Giraudo, A.; Pallavicini, M.; Bolchi, C. Small molecule ligands for α9 and α7 nicotinic receptors: A survey and an update, respectively. Pharmacol. Res. 2023, 193, 106801. DOI: https://doi.org/10.1016/j.phrs.2023.106801
  20. Toda, N. Nicotine-induced relaxation in isolated canine cerebral arteries. J. Pharmacol. Exp. Ther. 1975, 193, 376–384.
  21. Maeda, Y.I.; Okita, W.; Ichimura, K. Increased nasal patency caused by smoking and contraction of isolated human nasal mucosa. Rhinology 2004, 42, 63–67.
  22. Schick, S.F.; van den Vossenberg, G.; Luo, A.; et al. Thirty minute-exposure to aged cigarette smoke increases nasal congestion in nonsmokers. J. Toxicol. Environ. Health A 2013, 76, 601–613. DOI: https://doi.org/10.1080/15287394.2013.800811
  23. Mayhan, W.G. Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch. J. Lab. Clin. Med. 1999, 133, 48–54.